High expression of miR-363 predicts poor prognosis and guides treatment selection in acute myeloid leukemia

High expression of miR-363 predicts poor prognosis and guides treatment selection in acute myeloid leukemia

Abstract Background Acute myeloid leukemia (AML) is a highly heterogeneous malignancy with various outcomes, and therefore needs better risk stratification tools to help select optimal therapeutic options. Methods In this study, we identify miRNAs that could predict clinical outcome in a heterogeneo...

Full description

Bibliographic Details
Main Authors: Huihui Zhang, Ninghan Zhang, Rong Wang, Tingting Shao, Yuan Feng, Yao Yao, Qingyun Wu, Shengyun Zhu, Jiang Cao, Huanxin Zhang, Zhenyu Li, Xuejiao Liu, Mingshan Niu, Kailin Xu
Format: Article
Language:English
Published: BMC 2019-04-01
Series:Journal of Translational Medicine
Subjects:
Mir-363
Acute myeloid leukemia
Clinical outcome
Chemotherapy
Allo-HSCT
Online Access:http://link.springer.com/article/10.1186/s12967-019-1858-7

Internet

http://link.springer.com/article/10.1186/s12967-019-1858-7

Similar Items